Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Neutrophil‐to‐lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non‐small‐cell lung cancer.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request